Avirmax Biopharma, Inc., a leader in developing the next generation of AAV gene therapies, today announced the commencement of Investigational New Drug (IND)-enabling studies of ABI-201, a potential ...

SkylineDx, an innovative diagnostics company specializing in the research and development of molecular diagnostics for oncology, and inflammatory and infectious diseases, announces ...

The lab of Filippo Veglia, Ph.D., at The Wistar Institute has discovered a previously unknown mechanism for how aggressive ...

Intellia Therapeutics is a gene editing company focused on the development of Crispr/Cas9-based therapeutics. Intellia's technology platform specializes in Clustered Regularly Interspaced Short ...

ITF, IntraBio and Orchard are among the companies that have won FDA nods in the past year for Duchenne muscular dystrophy, ...

In Unreliable: Bias, Fraud, and the Reproducibility Crisis in Biomedical Research, published next week by Columbia University ...

Shortly after he won re-election in November, President Donald Trump announced that Musk and Ramaswamy (a failed presidential ...

Gene Hackman’s “last event,” according to his pacemaker, was on Feb. 17—nine days before his body was found. The Oscar-winning actor, his wife Betsy Arakawa, and one of their dogs were all discovered ...

Results of the Planned Interim Analysis and Update on Topline Read-out for the Essential3 Program: The Independent Data ...

A study led by UMass Chan researchers demonstrated that a gene therapy to correct a mutation that causes maple syrup urine disease (MSUD) prevented ...